vs
Osisko Development Corp.（ODV）与Profound Medical Corp.（PROF）财务数据对比。点击上方公司名可切换其他公司
Osisko Development Corp.的季度营收约是Profound Medical Corp.的1.7倍（$10.4M vs $6.0M）
奥西斯科开发公司是一家总部位于加拿大的矿业勘探开发企业，专注于高品位黄金及其他贵金属资产开发，核心项目主要分布在北美地区，业务覆盖矿产勘探、可行性研究、投产前准备等阶段，遵循可持续采矿标准运营。
康派集团医疗SE & Co. KGaA是一家总部位于德国科布伦茨的上市软件企业，专注于为医疗领域开发并提供相关软件产品，面向诊所、药房、医学实验室与医院推出支持诊疗及运营工作的云化数字应用软件。截至2022年，该公司全球员工规模超9200人，业务覆盖56个国家，拥有超过160万用户。
ODV vs PROF — 直观对比
营收规模更大
ODV
是对方的1.7倍
$6.0M
损益表 — Q3 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.4M | $6.0M |
| 净利润 | — | $-8.2M |
| 毛利率 | 3.2% | 66.8% |
| 营业利润率 | -149.3% | -123.3% |
| 净利率 | — | -136.8% |
| 营收同比 | — | — |
| 净利润同比 | — | — |
| 每股收益（稀释后） | — | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ODVPROF
| Q4 25 | — | $6.0M | ||
| Q3 25 | — | $5.1M | ||
| Q2 25 | — | $2.0M | ||
| Q1 25 | — | $2.3M | ||
| Q3 24 | $10.4M | — | ||
| Q2 24 | $10.8M | — | ||
| Q2 23 | $22.0M | — | ||
| Q3 22 | $4.7M | — |
净利润ODVPROF
| Q4 25 | — | $-8.2M | ||
| Q3 25 | — | $-8.0M | ||
| Q2 25 | — | $-15.7M | ||
| Q1 25 | — | $-10.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | $-23.8M | — | ||
| Q3 22 | $-76.8M | — |
毛利率ODVPROF
| Q4 25 | — | 66.8% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 81.7% | ||
| Q1 25 | — | 79.2% | ||
| Q3 24 | 3.2% | — | ||
| Q2 24 | — | — | ||
| Q2 23 | 28.2% | — | ||
| Q3 22 | — | — |
营业利润率ODVPROF
| Q4 25 | — | -123.3% | ||
| Q3 25 | — | -176.2% | ||
| Q2 25 | — | -696.9% | ||
| Q1 25 | — | -477.0% | ||
| Q3 24 | -149.3% | — | ||
| Q2 24 | -124.0% | — | ||
| Q2 23 | -241.5% | — | ||
| Q3 22 | -1940.8% | — |
净利率ODVPROF
| Q4 25 | — | -136.8% | ||
| Q3 25 | — | -157.7% | ||
| Q2 25 | — | -792.3% | ||
| Q1 25 | — | -458.1% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | -108.2% | — | ||
| Q3 22 | -1641.7% | — |
每股收益（稀释后）ODVPROF
| Q4 25 | — | $0.27 | ||
| Q3 25 | — | $0.26 | ||
| Q2 25 | — | $0.52 | ||
| Q1 25 | — | $0.36 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q3 22 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $59.7M |
| 总债务越低越好 | — | $4.5M |
| 股东权益账面价值 | — | $66.4M |
| 总资产 | — | $77.5M |
| 负债/权益比越低杠杆越低 | — | 0.07× |
8季度趋势，按日历期对齐
现金及短期投资ODVPROF
| Q4 25 | — | $59.7M | ||
| Q3 25 | — | $24.8M | ||
| Q2 25 | — | $35.2M | ||
| Q1 25 | — | $46.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q3 22 | — | — |
总债务ODVPROF
| Q4 25 | — | $4.5M | ||
| Q3 25 | — | $4.5M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $4.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q3 22 | — | — |
股东权益ODVPROF
| Q4 25 | — | $66.4M | ||
| Q3 25 | — | $32.1M | ||
| Q2 25 | — | $39.3M | ||
| Q1 25 | — | $50.8M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q3 22 | — | — |
总资产ODVPROF
| Q4 25 | — | $77.5M | ||
| Q3 25 | — | $42.3M | ||
| Q2 25 | — | $49.7M | ||
| Q1 25 | — | $60.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q3 22 | — | — |
负债/权益比ODVPROF
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.09× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q3 22 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-6.6M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ODVPROF
| Q4 25 | — | $-6.6M | ||
| Q3 25 | — | $-9.6M | ||
| Q2 25 | — | $-13.7M | ||
| Q1 25 | — | $-8.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q3 22 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
